COVID-19 Pneumonia
📧 Sign up to get email alerts when something new happens for COVID-19 Pneumonia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-10-15Clinical Trial Update: Evaluation of Immunogenicity and Safety of Combined Immunization of COVAX (Produced in Wuhan) and PPV23 / IIV4 [Phase 4]
Phase 4 trial evaluating immunogenicity and safety of combined immunization with COVAX (produced in Wuhan) and PPV23 / IIV4.
-
CLINICAL_TRIALS trial_result · 2021-10-06Clinical Trial Update: Pilot Study of Cefditoren Pivoxil in COVID-19 Patients With Mild to Moderate Pneumonia [Phase 4]
Pilot Phase 4 study assessing cefditoren pivoxil in adults with mild to moderate COVID-19 pneumonia has completed.
-
CLINICAL_TRIALS trial_result · 2021-09-27Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Tocilizumab in Hospitalized Participants With COVID-19 Pneumonia [Phase 3]
Phase 3 trial update evaluating tocilizumab for COVID-19 pneumonia in hospitalized patients has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-09-17Clinical Trial Update: Safety and Effectiveness of an Immunobiological Drug in CoViD-19 [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial update reports on the safety and effectiveness of an immunobiological drug for COVID-19 pneumonia and respi…
-
CLINICAL_TRIALS trial_result · 2021-09-08Clinical Trial Update: Efficacy and Safety of Oral Immunotherapy With GcMAF in Hospitalized Patients With COVID-19 Pneumonia [Phase 2]
Phase 2 trial update evaluating oral immunotherapy with GcMAF in hospitalized COVID-19 pneumonia patients reports efficacy and safety data.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-08-30Clinical Trial Update: A Study to Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia [Phase 2]
Phase 2 trial evaluating intravenous tocilizumab for moderate to severe COVID-19 pneumonia has completed; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-08-12Clinical Trial Update: Randomized, Unicentric, Open, Controlled Clinical Trial, in Phase Iii, to Demonstrate the Effectiveness of Tocilizumab [Phase 3]
A Phase 3 randomized trial investigating the effectiveness of tocilizumab for COVID-19 pneumonia; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2021-08-03Clinical Trial Update: Effect of Cyproheptadine on Ventilatory Support-free Days in Critically Ill Patients With COVID-19 [Phase 3]
Phase 3 trial investigating whether cyproheptadine affects ventilatory support-free days in critically ill COVID-19 pneumonia patients; curr…
-
CLINICAL_TRIALS trial_result · 2021-08-03Clinical Trial Update: Clinical Trial to Evaluate Efficacy of 3 Types of Treatment in Patients With Pneumonia by COVID-19 [Phase 2]
Clinical trial evaluating three treatments for COVID-19 pneumonia (Phase 2) with unknown current status.
-
CLINICAL_TRIALS trial_result · 2021-08-02Clinical Trial Update: Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of CKD-314 [Phase 3]
Phase 3 clinical trial evaluating CKD-314 for COVID-19 pneumonia; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2021-07-13Clinical Trial Update: MANS-NRIZ Trial for COVID-19 Treatment : Extension Study [Phase 2, Phase 3]
Clinical trial update for the MANS-NRIZ extension study in COVID-19 pneumonia, spanning Phase 2 and Phase 3.
-
CLINICAL_TRIALS trial_result · 2021-06-30Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia [Phase 3]
Phase 3 trial evaluating safety and efficacy of tocilizumab in patients with severe COVID-19 pneumonia has completed; results were posted in…
-
CLINICAL_TRIALS trial_result · 2021-06-22Clinical Trial Update: IRAK 4 Inhibitor (PF-06650833) in Hospitalized Patients With COVID-19 Pneumonia and Exuberant Inflammation. [Phase 2]
Phase 2 clinical trial investigating an IRAK 4 inhibitor (PF-06650833) for hospitalized COVID-19 pneumonia with exuberant inflammation.
-
CLINICAL_TRIALS trial_result · 2021-06-10Clinical Trial Update: Prevention of COVID-19 Infection to Severe Pneumonia or ARDS [Phase 2]
Phase 2 clinical trial update investigating prevention of progression from COVID-19 infection to severe pneumonia or ARDS.
-
CLINICAL_TRIALS trial_result · 2021-06-08Clinical Trial Update: Mineralocorticoid Receptor Antagonist and Pulmonary Fibrosis in COVID-19. [Phase 4]
A phase 4 clinical trial evaluating a mineralocorticoid receptor antagonist for COVID-19 pneumonia; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2021-06-01Clinical Trial Update: Clinical Trial of the Use of Anakinra in Cytokine Storm Syndrome Secondary to Covid-19 (ANA-COVID-GEAS) [Phase 2, Phase 3]
Clinical trial update for anakinra in cytokine storm syndrome related to COVID-19 (ANA-COVID-GEAS) completed phase 2 and phase 3.
-
CLINICAL_TRIALS trial_result · 2021-05-26Clinical Trial Update: Convalescent Plasma Compared to the Best Available Therapy for the Treatment of SARS-CoV-2 Pneumonia [Phase 2]
Phase 2 trial comparing convalescent plasma to best available therapy for SARS-CoV-2 pneumonia has completed.
-
CLINICAL_TRIALS trial_result · 2021-05-17Clinical Trial Update: Glucocorticoids in COVID-19 (CORTIVID) [Phase 3]
Phase 3 trial update for glucocorticoids in COVID-19 pneumonia (CORTIVID) has completed.
-
CLINICAL_TRIALS trial_result · 2021-05-14Clinical Trial Update: Ivermectina Colombia (IVERCOL) [Phase 2, Phase 3]
Clinical trial update for ivermectin (IVERCOL) in COVID-19 pneumonia spanning Phase 2 and Phase 3, status currently unknown.
-
CLINICAL_TRIALS trial_result · 2021-05-06Clinical Trial Update: Pilot Study for Cyproheptadine in Hospitalized Patient for COVID-19 [Phase 2]
Pilot Phase 2 trial evaluating cyproheptadine in hospitalized COVID-19 patients; current status unknown.
-
CLINICAL_TRIALS trial_result · 2020-11-30Clinical Trial Update: Convalescent Plasma vs Human Immunoglobulin to Treat COVID-19 Pneumonia [Phase 3]
Phase 3 trial comparing convalescent plasma to human immunoglobulin for COVID-19 pneumonia has completed.
-
CLINICAL_TRIALS trial_result · 2020-11-10Clinical Trial Update: plasmApuane CoV-2 : Efficacy and Safety of Immune Covid-19 Plasma in Covid-19 Pneumonia in Non ITU Patients [Phase 2]
A Phase 2 clinical trial evaluating the efficacy and safety of Immune Covid-19 Plasma for COVID-19 pneumonia in non-ICU patients is underway…
-
CLINICAL_TRIALS trial_result · 2020-09-07Clinical Trial Update: Cyclosporine A Plus Low-steroid Treatment in COVID-19 Pneumonia [Phase 1, Phase 2]
A clinical trial explores cyclosporine A combined with low-steroid treatment for COVID-19 pneumonia in Phase 1/2.
-
CLINICAL_TRIALS trial_result · 2020-09-01Clinical Trial Update: Oral Prednisone Regimens to Optimize the Therapeutic Strategy in Patients With Organizing Pneumonia Post-COVID-19 [Phase 4]
Phase 4 trial evaluating oral prednisone regimens to optimize therapy in patients with organizing pneumonia after COVID-19.
-
CLINICAL_TRIALS trial_result · 2020-07-08Clinical Trial Update: Treatment of Coronavirus COVID-19 Pneumonia (Pathogen SARS-CoV-2) With Cryopreserved Allogeneic P_MMSCs and UC-MMSCs [Phase 1, Phase 2]
Clinical trial update for COVID-19 pneumonia using cryopreserved allogeneic P_MMSCs and UC-MMSCs across Phase 1 and Phase 2.